Page 3 - Memory Cells News Today : Breaking News, Live Updates & Top Stories | Vimarsana

>> i got breaking news for you on this today, bill. that story in the "new york times" is a big deal. it focuses on a study coming out of rockefeller university. you don't see the author in front of a microphone or taking victory lapse but in the lab throughout the pandemic studying covid and he has determined after the third booster, the third shot, the booster for the vast majority of us you get t-cells and memory cells ready to attack the virus when it comes in. who should get the fourth shot? not you and me. people at high risk and can't mount an immune response. the fourth shot and we sta...

With the majority of the world population being either immunized against COVID-19 or having recovered from infection, people have rightly begun to ask: How long will the immunity provide immune protection?

Longer than the first two vaccines where we knew we needed boosters five to six months later. but there are some preprint studies that show that immunity from a booster might decrease after about ten weeks, which is why you're seeing countries like israel going to a fourth shot but i will tell you, none of these studies can pick up on memory cells, which are great and have really kicked in to help protect us against infections so i think more data will come forward to show boosters last a lot longer than we think. >> this is a good one. if you were in close contact with a friend for more than ...

You said we still need to keep the number 1 priority on getting more americans vaxed. talk to us about that. >> we haven't decided if we want the vaccine. if we decide what we want from every vaccine, protection against serious illness, the kind of illness that causes you to see a doctor's care or go to the icu, these vaccines do that because they create excellent memory cells. those are long-lived. so you should be protected for a while even against the omicron variant as we learned from the south african studies. you get 70% protection against serious illness. now, kind of provides against m...

And so the question is, you know, whether or not, which dose is sufficient. one. but also, two, we saw with the larger dose people had adverse effects with that. the other question is how does this translate into clinical outcomes? severe disease, hospitalations, and deaths sf we don't know whether this booster has any impact yet. all we know is lab data showing increase in antibodies. we know the immune system is complicated. there are cells involved. a very sophisticated system. we know they also have memory cells. that may also influence people's long-term outcome and immune response. there...